STAAB THOMAS R II (Chief Financial Officer) received a stock award from TENAX THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 5/13/2026ACC: 0001193125-26-221926
Officer· Chief Financial Officer
Since May 2026
+460K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
460K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+10K
Price / share
—
Trade value
—
% of position
New position
5/11/2026
0.00→10K
Total
Net shares
+10K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/11/2026 | A · Award | +10K | — | — | New position | 0.00 | 10K |
| Total | +10K | $0.00 | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
450K shares
Shares
+450K
Strike price
11.95
Held after
450K
Exercisable
—
5/11/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock450K shares | 5/11/2026 | A · Award | +450K | 11.95 | — | 450K |